SM
Sawicki Mark W
Directeur Scientifique
OtherM
Insider track record
ExecutiveAcross 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Sawicki Mark W, Directeur Scientifique. Director active across 2 companies, notably Cryoport, Inc.. Cumulatively, 13 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €57k. History available since 11 August 2021. The latest transaction was disclosed on 24 March 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations13 total
1,349 shares@ US$6.941612.5% of flowCommon StockSEC:0001104659-25-028324:0
9,000 shares0Common StockSEC:0001104659-25-025193:0
2,667 shares0Common StockSEC:0001104659-25-022644:0
1,367 shares@ US$17.542332.1% of flowCommon StockSEC:0001104659-24-039193:0
2,666 shares0Common StockSEC:0001104659-24-036284:0
1,000 shares@ US$12.7917.2% of flowCommon StockSEC:0001104659-23-100488:0
10,455 shares0Common StockSEC:0001104659-23-036712:0
1,362 shares@ US$20.7938.2% of flowCommon StockSEC:0001104659-23-033873:0
2,667 shares0Common StockSEC:0001104659-23-031940:0
10,455 shares0Common StockSEC:0001104659-22-034629:0
2,667 shares0Common StockSEC:0001104659-22-032997:0
77,625 shares@ US$7.800.11% mcap50.0% of flowCommon StockSEC:0001104659-21-105168:0
77,625 shares@ US$7.8050.0% of flowCommon StockSEC:0001104659-21-105168
About Sawicki Mark W
Mark W. Sawicki is the Chief Scientific Officer at Cryoport, Inc. In this role, he is responsible for scientific strategy and innovation. His expertise in research and development is essential for developing new products and solutions. He plays a key role in implementing new ideas and technologies within the company.